Trial Details
UNKNOWNBasic Information
| Clinical ID | c1694 |
|---|---|
| Identifier | NCT04548583 |
| Trial Title | Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Colitis |
| Interventions | DRUG: Remestemcel-L|DRUG: Remestemcel-L|OTHER: Placebo |
Participant Information
| Sponsor | The Cleveland Clinic |
|---|---|
| City | Cleveland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2020-11-04 |
|---|---|
| Primary Completion Date | 2025-10-23 |
| Completion Date | 2025-10-23 |